Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-May-22 5:49 PM View:  | OvaScience, Inc. (MLND) | 29-Apr-22 | Purchase | 2,118,640 | $2.36 | $5,000,000.00 | 97% 2.18M to 4.3M | |
| 29-Jun-21 9:54 PM View: | OvaScience, Inc. (MLND) | 25-Jun-21 | Grant | 2,176,410 | -- | -- | 100% 0 to 2.18M | |
| 15-Jun-21 4:43 PM View: | Aligos Therapeutics, Inc. (ALGS) | 11-Jun-21 | Acquisition (other) | 18,102 | -- | -- | < 1% 2.81M to 2.83M | |
| 15-Jun-21 4:43 PM View: | Aligos Therapeutics, Inc. (ALGS) | 11-Jun-21 | Acquisition (other) | 2,226 | -- | -- | < 1% 2.83M to 2.83M | |
| 15-Jun-21 4:43 PM View: | Aligos Therapeutics, Inc. (ALGS) | 11-Jun-21 | Disposition (other) | 18,102 | -- | -- | (< 1%) 2.83M to 2.81M | |
| 15-Jun-21 4:43 PM View: | Aligos Therapeutics, Inc. (ALGS) | 11-Jun-21 | Disposition (other) | 485,979 | -- | -- | (17%) 2.81M to 2.32M | |
| 28-Apr-21 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 26-Apr-21 | Acquisition (other) | 18,105 | -- | -- | < 1% 3.29M to 3.31M | |
| 28-Apr-21 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 26-Apr-21 | Acquisition (other) | 2,226 | -- | -- | < 1% 3.31M to 3.31M | |
| 28-Apr-21 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 26-Apr-21 | Disposition (other) | 18,105 | -- | -- | (< 1%) 3.31M to 3.29M | |
| 28-Apr-21 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 26-Apr-21 | Disposition (other) | 485,979 | -- | -- | (15%) 3.29M to 2.81M | |
| 04-Jan-21 6:02 PM View: | Gritstone Bio, Inc. (GRTS) | 30-Dec-20 | Market Purchase | 1,347,710 | $3.71 | $5,000,000.00 | 43% 3.1M to 4.45M | 6% |
| 16-Dec-20 5:10 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 14-Dec-20 | Acquisition (other) | 12,783 | -- | -- | 212% 6.04K to 18.82K | |
| 20-Oct-20 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 20-Oct-20 | Conversion | 3,092,340 | -- | -- | 100% 0 to 3.09M | |
| 20-Oct-20 5:00 PM View: | Aligos Therapeutics, Inc. (ALGS) | 20-Oct-20 | Purchase Duplicate | 200,000 | $15.00 | $3,000,000.00 | 6% 3.09M to 3.29M | |
| 03-Mar-20 6:57 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Conversion | 4,734,770 | -- | -- | 100% 0 to 4.73M | |
| 03-Mar-20 6:57 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 225,000 | $18.00 | $4,050,000.00 | 5% 4.73M to 4.96M | |
| 02-Oct-18 5:29 PM View: | Gritstone Bio, Inc. (GRTS) | 02-Oct-18 | Conversion Duplicate | 3,102,930 | -- | -- | 100% 0 to 3.1M | |
| 17-May-18 5:11 PM View: | Crispr Therapeutics Ag (CRSP) | 15-May-18 | Market Sale | 44,000 | $57.99 | $2,551,440.00 | (6%) 689.64K to 645.64K | (199%) |
| 09-May-18 5:15 PM View: | Crispr Therapeutics Ag (CRSP) | 08-May-18 | Market Sale (Planned) | 1,653 | $51.45 | $85,046.90 | (< 1%) 1.36M to 1.36M | (237%) |
| 09-May-18 5:15 PM View: | Crispr Therapeutics Ag (CRSP) | 07-May-18 | Market Sale (Planned) Duplicate | 119,709 | $50.38 | $6,030,830.00 | (8%) 1.48M to 1.36M | (244%) |
| 02-May-18 6:00 PM View: | Crispr Therapeutics Ag (CRSP) | 30-Apr-18 | Market Sale (Planned) Duplicate | 30,566 | $50.29 | $1,537,140.00 | (2%) 1.51M to 1.48M | (244%) |
| 30-Apr-18 8:57 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Apr-18 | Market Sale (Planned) | 11,648 | $50.02 | $582,655.00 | (< 1%) 1.52M to 1.51M | (246%) |
| 30-Apr-18 8:57 PM View: | Crispr Therapeutics Ag (CRSP) | 26-Apr-18 | Market Sale (Planned) | 210,610 | $50.11 | $10,553,800.00 | (12%) 1.73M to 1.52M | (246%) |
| 26-Apr-18 5:01 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Apr-18 | Market Sale (Planned) Duplicate | 22,841 | $50.99 | $1,164,660.00 | (1%) 1.75M to 1.73M | (240%) |
| 24-Apr-18 7:42 PM View: | Crispr Therapeutics Ag (CRSP) | 23-Apr-18 | Market Sale (Planned) Duplicate | 101,994 | $50.68 | $5,168,900.00 | (2%) 4.11M to 4.01M | (242%) |
| 24-Apr-18 7:42 PM View: | Crispr Therapeutics Ag (CRSP) | 20-Apr-18 | Acquisition (other) Duplicate | 92,918 | -- | -- | 2% 4.61M to 4.7M | |
| 24-Apr-18 7:42 PM View: | Crispr Therapeutics Ag (CRSP) | 20-Apr-18 | Acquisition (other) | 2,323 | -- | -- | < 1% 4.7M to 4.71M | |
| 24-Apr-18 7:42 PM View: | Crispr Therapeutics Ag (CRSP) | 20-Apr-18 | Disposition (other) Duplicate | 592,918 | -- | -- | (13%) 4.71M to 4.11M | |
| 27-Dec-17 4:14 PM View: | Crispr Therapeutics Ag (CRSP) | 22-Dec-17 | Market Sale (Planned) | 3,059 | $20.29 | $62,070.50 | (38%) 8.02K to 4.96K | (754%) |
| 28-Nov-17 4:11 PM View: | Crispr Therapeutics Ag (CRSP) | 27-Nov-17 | Market Sale (Planned) | 200 | $20.24 | $4,048.00 | (2%) 8.22K to 8.02K | (756%) |
| 28-Nov-17 4:11 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Nov-17 | Market Sale (Planned) | 1,700 | $20.21 | $34,357.90 | (17%) 9.92K to 8.22K | (757%) |
| 07-Sep-17 9:33 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Sep-17 | Acquisition (other) Duplicate | 311,052 | -- | -- | 5% 6.91M to 7.22M | |
| 07-Sep-17 9:33 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Sep-17 | Acquisition (other) | 9,918 | -- | -- | < 1% 7.22M to 7.23M | |
| 07-Sep-17 9:33 PM View: | Crispr Therapeutics Ag (CRSP) | 05-Sep-17 | Disposition (other) Duplicate | 2,614,160 | -- | -- | (36%) 7.23M to 4.62M | |
| 14-Jun-17 7:11 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 12-Jun-17 | Grant | 22,727 | -- | -- | 48% 47.65K to 70.38K | |
| 01-May-17 8:20 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 28-Apr-17 | Grant | 2,223 | -- | -- | 5% 45.43K to 47.65K | |
| 03-Apr-17 5:57 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 31-Mar-17 | Grant | 3,704 | -- | -- | 9% 41.73K to 45.43K | |
| 02-Mar-17 4:58 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 28-Feb-17 | Grant | 3,774 | -- | -- | 10% 37.95K to 41.73K | |
| 02-Feb-17 4:41 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 31-Jan-17 | Grant | 3,449 | -- | -- | 10% 34.5K to 37.95K | |
| 03-Jan-17 5:27 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 30-Dec-16 | Grant | 3,449 | -- | -- | 11% 31.05K to 34.5K | |
| 01-Dec-16 6:05 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 30-Nov-16 | Grant | 3,509 | -- | -- | 13% 27.55K to 31.05K | |
| 01-Nov-16 6:48 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 31-Oct-16 | Grant | 3,390 | -- | -- | 14% 24.16K to 27.55K | |
| 23-Dec-16 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Conversion Duplicate | 6,508,700 | -- | -- | 705% 923.66K to 7.43M | |
| 23-Dec-16 6:03 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Purchase Duplicate | 161,000 | $14.00 | $2,254,000.00 | 2% 7.43M to 7.59M | |
| 25-Jul-16 5:09 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Conversion Duplicate | 1,771,830 | -- | -- | 100% 0 to 1.77M | |
| 25-Jul-16 5:09 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Purchase Duplicate | 35,000 | $15.00 | $525,000.00 | 2% 1.77M to 1.81M | |
| 01-Jul-16 6:18 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 11-May-16 | Grant | 24,155 | -- | -- | 100% 0 to 24.16K |